蓝蜻蜓传染病监测系统
Search documents
IPO喜讯 | 分享投资已投项目「健康160」成功登陆港交所!
Sou Hu Cai Jing· 2025-09-17 12:05
Company Overview - Health 160 International Limited, established in 2005, is a leading digital healthcare service provider in China, focusing on connecting medical institutions, doctors, and users to offer comprehensive healthcare services [4][5] - The company ranks first in the Chinese digital healthcare service industry based on platform registration volume, number of partner hospitals, and healthcare personnel [5] Market Position and Performance - As of March 2025, Health 160 has connected over 44,600 healthcare institutions, including 14,400 hospitals (with 3,430 tertiary hospitals), and has registered over 55.2 million personal users with an average of 3.3 million monthly active users [5] - The company’s IPO on September 17, 2025, was met with strong market interest, with an oversubscription of 751.77 times for the public offering and 1.92 times for the international offering, reflecting high investor confidence in its business model and growth prospects [1] Industry Outlook - The Chinese digital healthcare market is projected to reach RMB 740.1 billion by 2030, with Health 160 positioned to lead industry innovation and integration through its platform operations and resource consolidation capabilities [7] - The company has developed digital tools such as the 160 Cloud Hospital and Blue Dragonfly Infectious Disease Monitoring System to enhance efficiency and reduce costs for healthcare institutions [9] Business Model and Growth Potential - Health 160 has established a mature business model that combines digital solutions with pharmaceutical sales, achieving a full-service chain that includes over 200 healthcare services [9] - The company has a significant expansion potential, currently leading the market in South China and extending its reach to 260 cities nationwide, with a standardized model that can be rapidly replicated [9]